Micardis and Mycophenolate Tablets Delayed Release
Determining the interaction of Micardis and Mycophenolate Tablets Delayed Release and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Telmisartan may decrease the blood levels and effects of mycophenolic acid. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your symptoms worsen or your condition changes during treatment with these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with telmisartan may decrease the plasma concentrations and therapeutic effects of mycophenolate mofetil (MMF). Concomitant use of telmisartan with MMF resulted in an approximately 30% decrease in mycophenolic acid (MPA) concentrations. The proposed mechanism is increased clearance due to telmisartan-mediated induction of UGT1A9. Adverse effects, such as graft rejection in transplant patients, have not been reported.
MANAGEMENT: Until more information is available, caution is advised when telmisartan is used concomitantly with mycophenolate mofetil. Dosage adjustments as well as clinical and laboratory monitoring should be considered.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. CellCept (mycophenolate mofetil)." Roche Laboratories, Nutley, NJ.
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Micardis-Mycophenolic acid
- Micardis-Mycophenolic Acid Delayed-Release Tablets
- Micardis-Mycophenolic Acid Tablets
- Micardis-Mycostatin (Nystatin Oral Suspension)
- Micardis-Mycostatin (Nystatin Tablets and Capsules)
- Micardis-Mycostatin Suspension
- Mycophenolate Tablets Delayed Release-Micardis HCT
- Mycophenolate Tablets Delayed Release-Micatin
- Mycophenolate Tablets Delayed Release-Micatin (Miconazole (Vaginal))
- Mycophenolate Tablets Delayed Release-Micatin (Miconazole Cream and Ointment)
- Mycophenolate Tablets Delayed Release-Micatin (Miconazole Spray and Spray Powder)
- Mycophenolate Tablets Delayed Release-Micatin Topical